Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancer Genetics and Cytogenetics|December 8, 2009
A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemiaIveta Sárová, Jana Brezinová, Zuzana Zemanová, et al.
Pediatric Blood & Cancer|April 12, 2011
CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
British Journal of Haematology|July 31, 2025
Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT studyMaximilian Schönung, Silvia Rathmann, Senthilkumar Ramamoorthy, et al.
Blood|May 25, 2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, et al.
Pediatric Blood & Cancer|September 18, 2009
Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometryEster Mejstríková, Eva Fronková, Tomás Kalina, et al.
Blood|May 24, 2003
Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7Gabriela Kardos, Irith Baumann, S Jane Passmore, et al.
Casopis Lekaru Ceskych|May 22, 2015
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial]Kateřina Zdráhalová, Jaroslav Štěrba, Jiří Domanský, et al.
Epigenetics|August 23, 2014
RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemiaAnna R Poetsch, Daniel B Lipka, Tania Witte, et al.
European Journal of Haematology|June 22, 2010
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 casesPetr Lemez, Andishe Attarbaschi, Marie C Béné, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009Hanna Gottschalk, Anja Möricke, Valentino Conter, et al.
Pageof 5